InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: davidal66 post# 700

Tuesday, 03/21/2017 12:17:18 PM

Tuesday, March 21, 2017 12:17:18 PM

Post# of 2099
Agree. It wouldn't surprise me if solid interim numbers lead to a buyout before ph3 is even over. That's why I hope the company doesn't sell. Avastin peak sales is around $6B (I think) so selling to Roche would be an ideal match. I would prefer a partnership over an acquisition in that scenario.

VB-111 may work for other indications so getting sold limits the company's potential to partner with other companies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News